Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:UMRX

Cogent Biosciences (UMRX) Stock Price, News & Analysis

Cogent Biosciences logo

About Cogent Biosciences Stock (NASDAQ:UMRX)

Advanced Chart

Key Stats

Today's Range
$10.64
$11.33
50-Day Range
$2.35
$13.01
52-Week Range
$0.29
$3.72
Volume
3.40 million shs
Average Volume
1.22 million shs
Market Capitalization
$466.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive UMRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter.

UMRX Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

UMRX Stock Analysis - Frequently Asked Questions

Cogent Biosciences, Inc. (NASDAQ:UMRX) issued its quarterly earnings data on Tuesday, August, 11th. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by $0.03. The company had revenue of $0.53 million for the quarter. Cogent Biosciences had a negative net margin of 96.84% and a negative trailing twelve-month return on equity of 87.78%.

Cogent Biosciences (UMRX) raised $75 million in an IPO on Thursday, March 29th 2018. The company issued 5,800,000 shares at a price of $12.00-$14.00 per share. Morgan Stanley and Cowen acted as the underwriters for the IPO and SunTrust Robinson Humphrey and Wedbush Securities were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cogent Biosciences investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Netflix (NFLX) and Alphabet (GOOG).

Company Calendar

Last Earnings
8/11/2020
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:UMRX
CIK
1622229
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.83 million
Net Margins
-96.84%
Pretax Margin
N/A
Return on Equity
-87.78%
Return on Assets
-52.14%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
2.90
Quick Ratio
2.90

Sales & Book Value

Annual Sales
$22.50 million
Price / Sales
20.72
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.04 per share
Price / Book
10.56

Miscellaneous

Outstanding Shares
42,469,000
Free Float
N/A
Market Cap
$466.31 million
Optionable
Not Optionable
Beta
3.93
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:UMRX) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners